Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T84634 | Target Info | |||
Target Name | Cytochrome P450 26 (CYP26A1) | ||||
Synonyms |
Retinoic acid-metabolizing cytochrome; Retinoic acid inducible enzyme; Retinoic acid 4-hydroxylase; P450RAI; P450 retinoic acid-inactivating 1; HP450RAI; Cytochrome P450RAI; CYP26A1
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | CYP26A1 | ||||
Biochemical Class | Paired donor oxygen oxidoreductase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Aromatase (CYP19A1) | Successful Target | ||||
UniProt ID | CP19A_HUMAN | |||||
Gene Name | CYP19A1 | |||||
Synonyms |
P-450AROM; Estrogen synthetase; Estrogen synthase; Cytochrome P450 19A1; Cytochrome P-450AROM; CYPXIX; CYP19; CYAR; ARO1
Click to Show/Hide
|
|||||
Representative Drug(s) | LIAROZOLE | Drug Info | IC50 = 5 nM | [1] | ||
Co-Target Name | Cytochrome P450 24 (CYP24A1) | Clinical trial Target | ||||
UniProt ID | CP24A_HUMAN | |||||
Gene Name | CYP24A1 | |||||
Synonyms |
Vitamin D(3) 24hydroxylase; Cytochrome P450CC24; CYP24A1; 24OHase; 1,25dihydroxyvitamin D(3) 24hydroxylase, mitochondrial
Click to Show/Hide
|
|||||
Representative Drug(s) | LIAROZOLE | Drug Info | IC50 = 2.3 nM | [2] | ||
Co-Target Name | Albendazole monooxygenase (CYP3A4) | Clinical trial Target | ||||
UniProt ID | CP3A4_HUMAN | |||||
Gene Name | CYP3A4 | |||||
Synonyms |
Taurochenodeoxycholate 6-alpha-hydroxylase; Quinine 3-monooxygenase; P450-PCN1; Nifedipine oxidase; NF-25; HLp; Cytochrome P450-PCN1; Cytochrome P450 NF-25; Cytochrome P450 HLp; Cytochrome P450 3A4; Cytochrome P450 3A3; CYPIIIA4; CYPIIIA3; CYP3A3; Albendazole sulfoxidase; Albendazole monooxygenase (sulfoxide-forming); 1,8-cineole 2-exo-monooxygenase
Click to Show/Hide
|
|||||
Representative Drug(s) | LIAROZOLE | Drug Info | IC50 = 690 nM | [3] | ||
Co-Target Name | Cytochrome P450 26B1 (CYP26B1) | Co-Target | ||||
UniProt ID | CP26B_HUMAN | |||||
Gene Name | CYP26B1 | |||||
Synonyms |
Cytochrome P450 26A2; Cytochrome P450 retinoic acid-inactivating 2; Cytochrome P450RAI-2; Retinoic acid-metabolizing cytochrome
Click to Show/Hide
|
|||||
Representative Drug(s) | Rambazole | Drug Info | IC50 = 0.46 nM | Click to Show More | [4] | |
2 | LIAROZOLE | Drug Info | IC50 = 18 nM | [4] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64. | ||||
REF 2 | Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation. J Med Chem. 2014 Sep 25;57(18):7702-15. | ||||
REF 3 | Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors. Bioorg Med Chem. 2015 Oct 15;23(20):6763-73. | ||||
REF 4 | Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase. J Med Chem. 2016 Mar 24;59(6):2579-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.